Assyro AI

Orange Book product · Brand (NDA)

GILENYA

FINGOLIMOD HYDROCHLORIDE

Brand (NDA)NDA 022527RX NOVARTIS

At a glance

May 11, 2018

Approved

Brand (NDA)

Application

Not listed

TE code

2

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    May 11, 2018

    8 yr 3 mo ago

  2. Today

  3. Patent 9592208 expires

    Listed drug product patent expiration.

    Mar 30, 2032

    in 5 yr 10 mo

  4. Patent 9592208*PED expires

    Listed listed patent expiration.

    Sep 30, 2032

    in 6 yr 5 mo

Pharmaceutical detail

Active ingredient

FINGOLIMOD HYDROCHLORIDE

Strength

EQ 0.25MG BASE

Dosage form

CAPSULE

Route

ORAL

TE code

Not listed

Application

NDA 022527

Product number

002

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (2)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
9592208Mar 30, 2032in 5 yr 10 mo
ProductU-2315
9592208*PEDSep 30, 2032in 6 yr 5 mo
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.